Level of evidence | |||
---|---|---|---|
Category | Quality of level | Source | CSCO expert consensus |
1A | High | Based on data from well‐structured and rigorously controlled meta‐analyses and/or large‐scale randomized controlled clinical trials | Uniform consensus (support level: ≥80%) |
1B | High | Based on data from well‐structured and rigorously controlled meta‐analyses and/or large‐scale randomized controlled clinical trials | Consensus with minimum disagreement (support level: 60%‐80%) |
2A | Relatively low | Based on data from meta‐analysis, small‐scale randomized controlled trials, well‐designed large‐scale retrospective studies, and/or case‐control studies | Uniform consensus (support level: ≥80%) |
2B | Relatively low | Based on data from meta‐analysis, small‐scale, randomized controlled trials, well‐designed large‐scale retrospective studies, and/or case‐control studies | Consensus with minimum disagreement (support level: 60%‐80%) |
3 | Low | Based on data from single‐arm clinical studies, case reports, and/or expert opinions | No consensus was reached, and had major disagreement (support level: <60%) |
Abbreviation: CSCO, Chinese Society of Clinical Oncology.